Evidence map›Paper›PMID 18596310›Full record

Trial reportJPEN. Journal of parenteral and enteral nutrition

Efficacy of parenteral nutrition supplemented with glutamine dipeptide to decrease hospital infections in critically ill surgical patients.

Concepción F Estívariz, Daniel P Griffith, Menghua Luo, Elaina E Szeszycki, Niloofar Bazargan, Nisha Dave, Nicole M Daignault, Glen F Bergman, Therese McNally, Cindy H Battey and 8 more

Open access · greenAbstract readRandomized Controlled Trial
In one paragraph

Trial report in JPEN. Journal of parenteral and enteral nutrition. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 10 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 10 pooled it
6.5field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 10 syntheses or guidelines pooled it, 103 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Glutamine supplementation for critically ill adults.The Cochrane database of systematic reviews · 2014
    Pooled it
  9. Pooled it
  10. Pooled it
  11. Trial
  12. Trial
  13. Review
  14. Occurrence of Multidrug-Resistant Strains ofTropical medicine and infectious disease · 2023
    Article
  15. Dynamic Gene Clusters Mediating Carbapenem-ResistantAntibiotics (Basel, Switzerland) · 2022
    Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 3 institutions in 2 countries.

Concepción F EstívarizEmory University Hospital Nutrition and Metabolic Support Service, Department of Medicine, Atlanta, GA 30322, USA.
Daniel P Griffith
Menghua Luo
Elaina E Szeszycki
Niloofar Bazargan
Nisha Dave
Nicole M Daignault
Glen F Bergman
Therese McNally
Cindy H Battey
Celeste E Furr
Li Hao
James G Ramsay
Carolyn R Accardi
George A Cotsonis
Dean P Jones
John R Galloway
Thomas R Ziegler
Emory University Hospital · USNutrition Sciences (Belgium) · BECancer Research And Biostatistics · US

Funding

CTSA INFRASTRUCTURE FOR PEDIATRIC RESEARCHUL1RR025008 · NCRR · EMORY UNIVERSITY · PI STEPHENS, DAVID S · 2007 to 2011
$29.0M
Atlanta Clinical and Translational Science Institute (ACTSI) RenewalUL1TR000454 · NCATS · EMORY UNIVERSITY · PI STEPHENS, DAVID S · 2012 to 2016
$25.8M
X LINKED NYSTAGMUS SYNDROME WITH FEATURES OF ALBINISMM01RR000039 · NCRR · EMORY UNIVERSITY · PI VACCARINO, VIOLA · 1985 to 2007
$21.3M
Patient Oriented Research in Clinical NutritionK24RR023356 · NCRR · EMORY UNIVERSITY · PI ZIEGLER, THOMAS R · 2007 to 2011
$839k
EFFICACY OF GLUTAMINE DIPEPTIDE IN CATABOLIC PATIENTSR03DK054823 · NIDDK · EMORY UNIVERSITY · PI ZIEGLER, THOMAS R · 1999 to 2000
$77k
NCATS NIH HHS UL1 TR000454NCRR NIH HHS K24 RR023356NCRR NIH HHS M01 RR000039NCRR NIH HHS M01 RR 00039NCRR NIH HHS UL1 RR025008NIDDK NIH HHS R03 DK054823NIDDK NIH HHS R03 DK 54823
6 · The paper itself

Abstract

backgroundNosocomial infections are an important cause of morbidity and mortality in the surgical intensive care unit (SICU). Clinical benefits of glutamine-supplemented parenteral nutrition may occur in hospitalized surgical patients, but efficacy data in different surgical subgroups are lacking. The objective was to determine whether glutamine-supplemented parenteral nutrition differentially affects nosocomial infection rates in selected subgroups of SICU patients.

methodsThis was a double-blind, randomized, controlled study of alanyl-glutamine dipeptide-supplemented parenteral nutrition in SICU patients requiring parenteral nutrition and SICU care after surgery for pancreatic necrosis, cardiac, vascular, or colonic surgery. Subjects (n = 59) received isocaloric/isonitrogenous parenteral nutrition, providing 1.5 g/kg/d standard glutamine-free amino acids (STD-PN) or 1.0 g/kg/d standard amino acids + 0.5 g/kg/d glutamine dipeptide (GLN-PN). Enteral feedings were advanced as tolerated. Nosocomial infections were determined until hospital discharge.

resultsBaseline clinical/metabolic data were similar between groups. Plasma glutamine concentrations were low in all groups and were increased by GLN-PN. GLN-PN did not alter infection rates after pancreatic necrosis surgery (17 STD-PN and 15 GLN-PN patients). In nonpancreatic surgery patients (12 STD-PN and 15 GLN-PN), GLN-PN was associated with significantly decreased total nosocomial infections (STD-PN 36 vs GLN-PN 13, P < .030), bloodstream infections (7 vs 0, P < .01), pneumonias (16 vs 6, P < .05), and infections attributed to Staphylococcus aureus (P < .01), fungi, and enteric Gram-negative bacteria (each P < .05).

conclusionsGlutamine dipeptide-supplemented parenteral nutrition did not alter infection rates following pancreatic necrosis surgery but significantly decreased infections in SICU patients after cardiac, vascular, and colonic surgery.

Indexed as

APACHECritical IllnessCross InfectionDietary SupplementsDipeptidesDouble-Blind MethodFemaleGlutamineHumansMaleMiddle AgedPancreasParenteral NutritionPostoperative PeriodSeverity of Illness IndexTreatment OutcomealanylglutamineDipeptidesGlutamine

Identifiers

PMID18596310
PMCPMC3062504
OpenAlexW2152935594

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.